Agios submits application for accelerated approval of mitapivat in sickle cell

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. APGE
6. MU
7. USO
8. HOOD
9. DFTX
10. RGNX

Go back to Agios submits application for accelerated approval of mitapivat in sickle cell
AGIOS PHARM (NASDAQ: AGIO) Delayed: 35.24 +1.08 (3.16%)
Previous Close $34.16    52 Week High $71.49 
Open $34.30    52 Week Low $33.50 
Day High $35.53    P/E N/A 
Day Low $34.30    EPS $-1.18 
Volume 467,423